amgen glp-1 GIPR antagonist antibodies conjugated to peptide are bispecific molecules that decrease weight in obese mice and monkeys: Cell Reports Medicine Ro partners with Amgen to

Best results are achieved alongside a healthy diet and consistent exercise

Stay on Track

Five clinical trials in type 2-diabetic subjects (SURPASS 15) have shown that tirzepatide at 515 mg per week reduces both HbA1c (1.24 to 2.58%) and body weight (5.411.7 kg) by amounts unprecedented for a single agent

GLP-1 drugs are remarkably effective at reducing visceral fat, which accumulates around the waist, surrounding and invading the liver, heart, and pancreas

The Protein-Muscle Problem Research shows that up to 20 to 25 percent of weight lost on GLP-1 medications can come from muscle rather than fat

Regulates appetite and blood sugar